Source: International Congress 2016 – Effect of sleep apnoea on life-span and comorbidities
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
Sema Saraç (Istanbul, Turkey), Sema Saraç, Gulgun Çetintas, Murat Kavas, Özlem Oruç, Özgür Bilgin Topçuoglu, Cüneyt Saltürk, Meral Uluköylü, Cansel Atinkaya, Sibel Arinç, Ali Metin Görgüner. OSA with intertitial lung diseases. Eur Respir J 2016; 48: Suppl. 60, 2357

Member's Comments

No comment yet.

Related content which might interest you: Rituximab in severe, treatment-refractory interstitial lung disease Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013 Study of factors affecting mortality in ILD cases over 2 years Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 Antisynthetase syndrome (AS) in patients with diffuse interstitial lung disease (ILD) Source: International Congress 2015 – Connective tissue disorders Year: 2015 Idiopathic non-specific interstitial pneumonia (iNSIP): do the patients develop connective tissue disease (CTD) during follow-up? Source: International Congress 2016 – Connective tissue disorders Year: 2016 Rituximab in severe, progressive interstitial lung disease Source: International Congress 2016 – Connective tissue disorders Year: 2016 Pulmonary involvement in children with rheumatic diseases Source: International Congress 2016 – Connective tissue disorders Year: 2016 HCMV infection triggers the development of interstitial lung diseases in autoimmune disorders Source: International Congress 2014 – IPF and surroundings Year: 2014 Evaluation of sleep related breathing disorders and obstructive sleep apnea in patients with interstitial lung disease Source: Annual Congress 2013 –Sleep disordered breathing in special situations II Year: 2013 Addition of respiratory hospitalizations 24weeks prior to the ILD-GAP model to predict mortality in chronic interstitial lung disease Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 Metabolic syndrome in interstitial lung diseases Source: International Congress 2015 – IIPs: orphan Year: 2015 Co-morbidities and cause of death in patients with rheumatoid arthritis associated interstitial lung disease Source: International Congress 2015 – Connective tissue disorders Year: 2015 A multicentre evaluation of inter-multidisciplinary team agreement for diagnosis in diffuse lung disease Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases Year: 2016 Clinical analysis of lung manifestation in Sjögren's syndrome Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013 Plethysmographic profil of patients with infiltrative lung diseases Source: Annual Congress 2013 –Clinical respiratory physiology in different diseases Year: 2013 "Cyclophosphamide for the treatment of inflammation driven fibrotic interstitial lung disease" Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 The prognostic factor in patients with myositis-associated interstitial lung disease Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 Prognostic factors of interstitial lung disease associated with primary Sjögren's syndrome Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Relevance of the expert ILD clinical-radiological evaluation of referred cases to the MDT Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 Safety and advantages of VATS biopsy in diagnosis of interstitial lung disease Source: International Congress 2015 – Challenges in surgery for non-malignant disorders: pleural mediastinal and tracheal problems, congenital disorders Year: 2015